PANACEA BIOTEC LTD. - Re-Designation Of Mr. Ankesh Jain As Whole-Time Director In The Company And Its Wholly Owned Subsidiary, Panacea Biotec Pharma Limited

Download	< Back
31 May 2024
The Board in its meeting held on 30.05.2024 approved the re-designation of Mr. Ankesh Jain from Whole-time director designated as Director Sales & Marketing to Whole-time Director of the Company for the remaining tenure of his Term i.e. from 01.06.2024 to 31.03.2025. The Board of Directors of the Company''s wholly owned subsidiary company, Panacea Biotec Pharma Ltd. has also re-designated Mr. Ankesh Jain who is currently acting as its non-executive Director, to the position of Whole-time Director w.e.f. 01.06.2024. Mr. Ankesh Jain is not debarred from holding the office of Whole-time director in the Company as well as Panacea Biotec Pharma Ltd, by virtue of SEBI order or any other such authority
View all announcements for PANACEA BIOTEC LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us